This MedLibrary.org supplementary page on Acetylation is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Acetylation (or in IUPAC nomenclature ethanoylation) describes a reaction that introduces an acetyl functional group into an organic compound. Deacetylation is the removal of the acetyl group.
Moreover, it is that process of introducing an acetyl group (resulting in an acetoxy group) into a compound, specifically, the substitution of an acetyl group for an active hydrogen atom. A reaction involving the replacement of the hydrogen atom of a hydroxyl group with an acetyl group (CH3 CO) yields a specific ester, the acetate. Acetic anhydride is commonly used as an acetylating agent reacting with free hydroxyl groups. For example, it is used in the synthesis of Aspirin.
Contents |
Acetylation of proteins
In biology, i.e. in living cells, acetylation occurs as a co-translational and post-translational modification of proteins, for example, histones, p53, and tubulins.
N-alpha-terminal Acetylation
Acetylation of the N-terminal alpha-amine of proteins is a widespread modification in eukaryotes. 40-50% of yeast proteins, and 80-90% of human proteins are modified in this manner, and the pattern of modification is found to be conserved throughout evolution. The modification is performed by N-alpha-acetyltransferases (NATs), a sub-family of the GNAT superfamily of acetyltransferases, which also include histone acetyl transferases. The GNATs transfer the acetylgroup from acetyl-coenzyme A to the amine group. The NATs have been most extensively studied in yeast. Here three NAT complexes, NatA/B/C, have been found to perform most N-alpha-terminal acetylations. They have sequence specificity for their substrates, and it is believed that they are associated with the ribosome, where they acetylate nascent polypeptides co-translationally.
In humans, only one NAT complex , the human NatA, has been identified and characterized. Subunits of the human NatA complex have been coupled to cancer-related processes such as hypoxia-response and the beta-catenin pathway. It has been found to be over-expressed in papillary thyroid carcinoma and neuroblastoma.
Despite being such a conserved and widespread modification, little is known about the biological role of N-alpha-terminal acetylation. Proteins such as actin and tropomyosin have been found to be dependent of NatB acetylation to form proper actin filaments. This is yet only an example of the potential importance of this modification.
Lysine Acetylation and Deacetylation
In histone acetylation and deacetylation, the histones are acetylated and deacetylated on lysine residues in the N-terminal tail as part of gene regulation. Typically, these reactions are catalyzed by enzymes with "histone acetyltransferase" (HAT) or "histone deacetylase" (HDAC) activity, although it should be noted that HATs and HDACs can modify the acetylation status of non-histone proteins as well.[1]
The regulation of transcription factors, effector proteins, molecular chaperones, and cytoskeletal proteins by acetylation / deacetylation is emerging as a significant post-translational regulatory mechanism [2] analogous to phosphorylation by the action of kinases or dephosphorylated by the action of phosphatases. Not only can the acetylation state of a protein modify its activity, there has been recent suggestion that this post-translational modification might crosstalk with phosphorylation, methylation, ubiquitination, sumoylation, and others for dynamic control of cellular signaling. [3]
The tubulin acetylation and deacetylation system is well worked out in Chlamydomonas. A tubulin acetyltransferase located in the axoneme acetylates a specific lysine residue in the α-tubulin subunit in assembled microtubule. Once disassembled, this acetylation can be removed by another specific deacetylase which is cytosolic. Thus the axonemal microtubules (long half life) carry this signature acetylation absent from cytosolic microtubules (short half life).
References
- ^ Sadoul K, Boyault C, Pabion M, Khochbin S (February 2008). "Regulation of protein turnover by acetyltransferases and deacetylases". Biochimie 90 (2): 306–12. doi:. PMID 17681659.
- ^ Glozak MA, Sengupta N, Zhang X, Seto E (2005). "Acetylation and deacetylation of non-histone proteins". Gene 363: 15-23. PMID 16289629.
- ^ Yang XJ, Seto E (2008). "Lysine acetylation: codified crosstalk with other posttranslational modifications". Mol Cell 31: 449-61. PMID 18722172.
See also
|
||||||||||||||||||||||||||||||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 5 October 2008, at 19:12.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Acetylation".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.